Sebastian Böselt

Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial

Albert C. Ludolph, Joachim Schuster, Johannes Dorst et al. · The Lancet Neurology · 2018 · 78 citations · Full text

Amyotrophic Lateral Sclerosis, Neurological Disorder, Medicine +5

Differential Sirtuin Expression Patterns in Amyotrophic Lateral Sclerosis (ALS) Postmortem Tissue: Neuroprotective or Neurotoxic Properties of Sirtuins in ALS?

Sonja Körner, Sebastian Böselt, Nadine Thau et al. · Neurodegenerative Diseases · 2012 · 60 citations

Lower motor neuron involvement in ALS assessed by motor unit number index (MUNIX): Long-term changes and reproducibility

Davood Fathi, Bahram Mohammadi, Reinhard Dengler et al. · Clinical Neurophysiology · 2016 · 50 citations

Amyotrophic Lateral Sclerosis, Health Sciences, Neurophysiology +12

The Axon Guidance Protein Semaphorin 3A Is Increased in the Motor Cortex of Patients With Amyotrophic Lateral Sclerosis

Sonja Körner, Sebastian Böselt, Klaudia Wichmann et al. · Journal of Neuropathology & Experimental Neurology · 2016 · 37 citations

Neurodegenerative Diseases, Neuromuscular Junction, Neuroregeneration +15

Intraspinal administration of human spinal cord-derived neural progenitor cells in the<i>G93A-SOD1</i>mouse model of ALS delays symptom progression, prolongs survival and increases expression of endogenous neurotrophic factors

Sarah Knippenberg, Klaus Jan Rath, Sebastian Böselt et al. · Journal of Tissue Engineering and Regenerative Medicine · 2015 · 28 citations